Fluticasone Furoate + Vilanterol Suppliers & Bulk Manufacturers
Available Forms: Powder For Inhalation(DPI/MDI)
Available Strengths: 92 mcg Fluticasone furoate / 22 mcg Vilanterol; 184 mcg Fluticasone furoate / 22 mcg Vilanterol
Reference Brands: Breo Ellipta®(US), Relvar Ellipta® (EU)
Category: Respiratory Disorder
Fluticasone furoate + Vilanterol is available in Powder For Inhalation(DPI/MDI) and strengths such as 92 mcg Fluticasone furoate / 22 mcg Vilanterol; 184 mcg Fluticasone furoate / 22 mcg Vilanterol. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Fluticasone furoate + Vilanterol is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Fluticasone furoate + Vilanterol can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description: Fluticasone furoate and Vilanterol is a powerful once-daily combination therapy used for the long-term treatment of asthma and chronic obstructive pulmonary disease (COPD). Marketed as Breo Ellipta® in the U.S. and Relvar Ellipta® in the EU, this inhalation powder combines Fluticasone, a corticosteroid that reduces inflammation, with Vilanterol, a long-acting beta-agonist (LABA) that relaxes airway muscles. Available in 92/22 mcg and 184/22 mcg strengths via the Ellipta® DPI, it offers 24-hour symptom control. Ideal for pharma B2B and export markets, this therapy enhances adherence and delivers effective respiratory relief with convenient once-daily dosing.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Mannitol
Strength:
40mg
Form: inhalation powder capsules
Reference Brands: Bronchitol (USA/EU)
View DetailsArformoterol Tartrate
Strength:
15 mcg per 2 mL
Form: solution for inhalation
Reference Brands: Brovana (USA/EU)
View DetailsQuick Response Guaranteed | Verified Suppliers